MORE►
treatments
Dr. David Genecov, left, and John Harkey of Dialectic Therapeutics. [Photos: Courtesy Dialectic Therapeutics]
Dialectic Therapeutics Plans to Further Cancer Drug Research Using $3M Seed Award
by Lance Murray | Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
by Lance Murray |
Feb 21, 2020
In this weekly roundup of research and development activity in North Texas, you’ll read about a study led by researchers at the University of Texas at Arlington that could lead to better treatment for osteoporosis, and the Center for BrainHealth seeking pilot phase participants.
MORE►
by Lance Murray |
Aug 2, 2019
You'll also find out about a team at UT Southwestern Medical Center that is working on new approaches to prevent and treat colorectal cancer in this roundup of research and development activity in North Texas.
MORE►
by Lance Murray |
Oct 12, 2018
Also, you'll learn how Galderma has boosted its R&D investment and boosted its clinical trials. Here are some of the research projects underway in North Texas that could make lives better.
MORE►
